TrialClinical cancer research : an official journal of the American Association for Cancer Research2016

Disruption of in vivo Chronic Lymphocytic Leukemia Tumor-Microenvironment Interactions by Ibrutinib--Findings from an Investigator-Initiated Phase II Study.

Carsten U Niemann et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.